Annual Lung SPORE Workshop (Abstract Submission)
75 submissions
Created | First Name | Last Name | Phone | Select a Session Topic | Abstract Title | First Author First Name | First Author Last Name | Affiliation | List of Additional Authors | Your Abstract Submission | Upload Abstract | Special Characters Included? | Abstract Review Status | Upload Poster | Poster Uploaded | Operations | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mon, 03/11/2024 - 14:03 | S. Lani | Park | lpark@cc.hawaii.edu | Session 2: Health Disparities in Lung Cancer | Racial and ethnic differences in the tumor immune microenvironment of lung adenocarcinomas | Lenora | Loo | University of Hawaii Cancer Center |
|
Abstract_Submission.pdf | Yes | Approved to be a Speaker | |||||
Mon, 03/11/2024 - 13:59 | Mustafa | Al-Dulaimi | mustafa_al-dulaimi@dfci.harvard.edu | 12087180181 | Session 6: Cancer Biology | CDK8/19 Co-inhibition Enhances Osimertinib Efficacy in EGFR Mutant Non-Small Cell Lung Cancers (NSCLC) | Mustafa | Al-Dulaimi | DFCI |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | ||||
Mon, 03/11/2024 - 13:57 | Nicole | Novaresi | nicole.novaresi@utsw.edu | Session 6: Cancer Biology | Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance response to MAPK pathway-targeted therapies in non-small cell lung cancer | Nicole | Novaresi | Department of Molecular Biology, UTSW |
|
Abstract_Submission.pdf | Yes | Approved to be a Speaker | |||||
Mon, 03/11/2024 - 13:43 | Wei | Wu | vivi2011@uw.edu | 2065434940 | Session 5: Early Detection and Screening | Schema for the plasma/CT matching and detection of lung cancer in a NLST-ACRIN cohort | Wei | Wu | University of Washington School of Medicine |
|
Abstract_Submission.pdf |
Wu_UW_Session 5.docx15.76 KB
|
No | Approved to be a Poster Presenter | |||
Mon, 03/11/2024 - 13:40 | Kelly | Becht | kelly.becht@yale.edu | (603) 401-2345 | Session 2: Health Disparities in Lung Cancer | Disparities in Stereotactic Radiosurgery Receipt in Patients with Brain Metastases from Non-Small Cell Lung Cancer | Kelly | Becht | Department of Therapeutic Radiology, Yale School of Medicine |
|
Abstract_Submission.pdf |
Becht_Yale_Session2_v2.docx17.49 KB
|
No | Approved to be a Poster Presenter |
![]() |
||
Mon, 03/11/2024 - 13:38 | Robert | Matera | robert.matera@yale.edu | Session 4: Small Cell Lung Cancer | Longitudinal tumor microenvironment analysis in dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with advanced stage small cell lung cancer | Anne | Chiang | Yale University / Smilow Cancer Center |
|
Abstract_Submission.pdf |
Chiang_Yale_4.docx157.98 KB
|
No | Approved to be a Poster Presenter | ||||
Mon, 03/11/2024 - 13:33 | Darin | Dolezal | darin.dolezal@yale.edu | 203-584-4276 | Session 6: Cancer Biology | Brain metastasis Fibrosis Predicts Clinical Outcomes and Response to Treatment in Patients with Non-Small Cell Lung Cancer | Darin | Dolezal | Yale School of Medicine - Department of Pathology |
|
Abstract_Submission.pdf | Yes | Approved to be a Poster Presenter | ||||
Mon, 03/11/2024 - 13:33 | Shannon | Silva | shannon.silva@yale.edu | 9784296866 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Unraveling the role of SWI/SNF complexes in acquired resistance to osimertinib in EGFR-mutant lung adenocarcinoma. | Shannon | Silva | Yale University |
|
Abstract_Submission.pdf |
Silva_Yale_Session1.docx21.47 KB
|
No | Approved to be a Poster Presenter |
![]() |
||
Mon, 03/11/2024 - 13:21 | Ramin | Salehi-Rad | rsalehirad@mednet.ucla.edu | 18185715627 | Session 3: Immuno-oncology | Hyper-Interferon Sensitive influenza induces adaptive immune responses and overcomes resistance to anti-PD-1 in murine NSCLC | Ramin | Salehi-Rad | David Geffen School of Medicine at UCLA |
|
Abstract_Submission.pdf |
RSR-LungSpore_2024-Abstract.docx15.62 KB
|
No | Approved to be a Poster Presenter | |||
Mon, 03/11/2024 - 13:21 | Hari Shankar | Sunil | harishankar.sunil@utsouthwestern.edu | 9727302166 | Session 3: Immuno-oncology, Session 6: Cancer Biology | Transmembrane Serine Protease TMPRSS11B promotes tumorigenesis in lung squamous cell carcinoma through enhanced lactate export and modulation of the tumor microenvironment | Hari Shankar | Sunil | UT Southwestern Medical Center |
|
Abstract_Submission.pdf | No | Approved to be a Poster Presenter | ||||
Mon, 03/11/2024 - 13:12 | Esra | Akbay | esra.akbay@utsouthwestern.edu | 2146484159 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Kras G12D inhibition causes tumor regression and synergizes with immune checkpoint blockade in immunogenic lung cancer models | Esra | Akbay | UT Southwestern Medical Center | Abstract_Submission.pdf |
Akbay_UTSW_Session 1.docx15.43 KB
|
No | Approved to be a Poster Presenter | ||||
Mon, 03/11/2024 - 13:09 | Arnaud | Augert | arnaud.augert@yale.edu | Session 4: Small Cell Lung Cancer | The chromatin remodeling complex PBAF functions as a bona fide tumor suppressor complex in SCLC | Arnaud | Augert | Yale University | Abstract_Submission.pdf | No | Approved to be a Speaker | ||||||
Mon, 03/11/2024 - 13:03 | Jensen | Abascal | jensenabascal@g.ucla.edu | (310) 266-8937 | Session 3: Immuno-oncology | In situ vaccination with Flt3l gene modified CD103+ type 1 conventional dendritic cells synergizes with anti-PD-1 checkpoint blockade in murine models of non-small cell lung cancer | Jensen | Abascal | Division of Pulmonary and Critical Care Medicine, Department of Medicine, UCLA. Molecular Biology Institute, UCLA. |
|
Abstract_Submission.pdf |
Abascal_UCLA_Session 3.docx16.92 KB
|
No | Approved to be a Poster Presenter | |||
Mon, 03/11/2024 - 12:48 | Yan | Yang | yyang32@mdanderson.org | 7137458407 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Enhanced Sensitivity of EGFR Inhibitor Resistant NSCLC and Drug Tolerant Persister Cells to Chimeric Antigen Receptor (CAR)-NK Cellular Therapy | Yan | Yang | MD Anderson Cancer Center |
|
Abstract_Submission.pdf | No | Approved to be a Speaker | ||||
Mon, 03/11/2024 - 12:23 | Savannah | Kandigian | savannah.kandigian@yale.edu | Session 6: Cancer Biology | Molecular and histological characterization of NSCLC progression to leptomeningeal metastasis with comorbid intraparenchymal disease | Savannah | Kandigian | Department of Pathology, Yale School of Medicine |
|
Abstract_Submission.pdf | Yes | Approved to be a Poster Presenter | |||||
Mon, 03/11/2024 - 12:15 | Elisabeth | Martinez | elisabeth.martinez@utsouthwestern.edu | Session 4: Small Cell Lung Cancer | Jumonji Histone Demethylases are Therapeutic Targets in Small Cell Lung Cancer | Aiden | Nguyen | UTSW |
|
Abstract_Submission.pdf |
Martinez_UTSW_#4.docx14.1 KB
|
No | Approved to be a Speaker | ||||
Mon, 03/11/2024 - 12:01 | Mark | Lee | mark.n.lee@yale.edu | 6178200262 | Session 3: Immuno-oncology | The antigen specificity of tumor-targeting T cells in non-small cell lung cancer | Berkay | Yahsi | Yale Department of Laboratory Medicine |
|
Abstract_Submission.pdf |
Lee_Yale_3.docx43.42 KB
|
No | Approved to be a Poster Presenter | |||
Mon, 03/11/2024 - 11:24 | Junghui | Koo | jkoo22@emory.edu | 404-323-3287 | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | Unlocking Immunochemotherapy Potentials for KRAS and LKB1 Mutant Lung Adenocarcinoma through FAK Inhibition and Immunotherapy with Anti-PD1 Antibody | Junghui | Koo | Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute of Emory University |
|
Abstract_Submission.pdf |
Koo_EmoryUniv_Session#1.docx13.22 KB
|
No | Approved to be a Poster Presenter | |||
Mon, 03/11/2024 - 11:19 | Shayna | Thomas-Jardin | shayna.thomas-jardin@utsouthwestern.edu | 2144630651 | Session 3: Immuno-oncology | The integrated stress response (ISR) pathway coordinately regulates multiple immune checkpoint proteins in lung cancer | Shayna | Thomas-Jardin | Department of Molecular Biology, UT Southwestern Medical Center |
|
Abstract_Submission.pdf | Yes | Approved to be a Poster Presenter | ||||
Mon, 03/11/2024 - 10:46 | Don | Nguyen | don.nguyen@yale.edu | Session 1: Oncogene-driven lung cancers and resistance to targeted therapies | The ATM Kinase as a Therapeutic Target in Drug Resistant NSCLC with Brain Metastasis | Don | Nguyen | Yale School of Medicine | Abstract_Submission.pdf |
Nguyen SPORE Workshop 2024.docx18.17 KB
|
No | Approved to be a Speaker |